Regardless of how involved we get in direct patient management of diabetes; our profession has always been tasked in training patients to effectively monitor glucose and help ensure safe and effective therapy. Our ability to accurately monitor glucose has evolved from urine dipsticks to capillary blood finger pokes, to continuous glucose monitoring (CGM). It may be less well known that there are both intermittently scanned (isCGM) and real-time
(rtCGM). There are fundamental differences that can affect which CGM offers the most utility to an individual patient. We will review differences that may help pharmacists decide which CGM type to best recommend in a particular situation. Advantages of “push” vs “pull” technology includes no scan and alerts that can predict a serious hypoglycemia event before it happens, improved time in range, improved A1C, and less hypoglycemia. Practical tips to navigate the continuously improving coverage landscape and effectively help patients start real-time CGM will be shared.

Sponsored by: Dexcom